Pre-analytical automation market seen reaching $11.38 billion by 2030

The Business Research Company says the pre-analytical automation market will grow from $7.04 billion in 2025 to $11.38 billion by 2030, driven by demand for faster, more accurate diagnostic workflows. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Pre-analytical automation is becoming a core part of diagnostic lab operations as providers push to reduce errors, speed up sample handling and improve consistency. - The market’s projected rise to $11.38 billion by 2030 signals rising spending on lab automation across healthcare systems. - Infectious disease testing is a key demand driver because faster, standardized specimen processing can improve turnaround times and reduce contamination risk.

What happened: - The Business Research Company projected the pre-analytical automation market will grow from $7.04 billion in 2025 to $7.74 billion in 2026. - The company forecast the market will reach $11.38 billion by 2030, implying a 10.1% compound annual growth rate from 2026 to 2030. - The report was released July 21, 2026, from London. - The company also published a free sample of the report and the full market report.

The details: - Pre-analytical automation covers automated tools and technologies used to streamline laboratory tasks before sample analysis. - The systems reduce manual handling and improve consistency, efficiency and reliability in early diagnostic workflows. - The forecast cites drivers including AI-enabled laboratory automation, precision diagnostics, faster turnaround times, integrated healthcare laboratory networks, smart hospital investments and tighter quality control. - Emerging trends include AI-powered workflow optimization, robotic handling systems, integrated laboratory information systems, smart barcode and specimen identification tools, and modular transport and sorting systems. - The report says North America held the largest market share in 2025 because of advanced healthcare infrastructure and early technology adoption. - The report says Asia-Pacific is expected to post the fastest growth during the forecast period as healthcare access expands and laboratory automation spending rises. - The geographic analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The growth outlook suggests lab automation is shifting from a back-end efficiency tool to a strategic investment tied to diagnostic volume, accuracy and operating speed. - Rising infectious disease rates add pressure on laboratories to process more samples with fewer errors, which strengthens the case for automation. - The regional split points to a mature North American market and a faster-expanding Asia-Pacific opportunity.

What's next: - The market is expected to keep expanding through 2030 as labs adopt more AI, robotics and integrated tracking systems. - The biggest gains will likely go to providers that can combine automation with data visibility, standardization and faster specimen throughput. - Healthcare operators in growth markets may accelerate purchases as lab networks expand and diagnostic demand rises.

The bottom line: - Pre-analytical automation is moving from niche efficiency upgrade to mainstream diagnostic infrastructure, with double-digit growth expected through the end of the decade.